{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:34:39Z","timestamp":1747204479711,"version":"3.40.5"},"posted":{"date-parts":[[2023,8,22]]},"group-title":"In Review","reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,2,9]]},"abstract":"<title>Abstract<\/title>\n        <p>Parkinson disease (PD) is closely linked to the misfolding and accumulation of \u03b1-synuclein (\u03b1-syn) into Lewy bodies. HtrA1 is a PDZ serine protease that degrades fibrillar tau, which is associated with Alzheimer disease (AD). Further, inactivating mutations to mitochondrial HtrA2 have been implicated in PD. Here, we establish that HtrA1 inhibits the aggregation of \u03b1-syn as well as FUS and TDP-43, which are implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). We demonstrate that the protease domain of HtrA1 is necessary and sufficient for inhibition of aggregation, yet this activity is independent of HtrA1 proteolytic activity. Further, we find that HtrA1 also disaggregates <italic>preformed<\/italic> \u03b1-syn fibrils, which may promote their clearance. Treatment of \u03b1-syn fibrils with HtrA1 renders \u03b1-syn incapable of seeding the aggregation of endogenous \u03b1-syn in mammalian biosensor cells. We find that HtrA1 remodels \u03b1-syn by specifically targeting the NAC domain, which is the key domain that catalyzes \u03b1-syn oligomerization and fibrillization. Finally, in a primary neuron model of \u03b1-syn aggregation, we show that HtrA1 and its proteolytically inactive form both detoxify \u03b1-syn and prevent the formation of hyperphosphorylated \u03b1-syn accumulations. Our findings suggest that HtrA1 prevents aggregation and promotes disaggregation of multiple disease-associated proteins, and may be a therapeutic target for treating a range of neurodegenerative disorders.<\/p>","DOI":"10.21203\/rs.3.rs-2570571\/v1","type":"posted-content","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:25:40Z","timestamp":1692735940000},"source":"Crossref","is-referenced-by-count":0,"title":["HtrA1 prevents and reverses \u03b1-synuclein aggregation, rendering it non-toxic and seeding incompetent"],"prefix":"10.21203","author":[{"given":"Sheng","family":"Chen","sequence":"first","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradhika","family":"Puri","sequence":"additional","affiliation":[{"name":"Washington University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braxton","family":"Bell","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Fritsche","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Palacios","sequence":"additional","affiliation":[{"name":"Washington University in St Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurie","family":"Balch","sequence":"additional","affiliation":[{"name":"Oklahoma State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macy","family":"Sprunger","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-2065","authenticated-orcid":false,"given":"Matthew","family":"Howard","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Patterson","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-6193","authenticated-orcid":false,"given":"Gary","family":"Patti","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Davis","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4406-9504","authenticated-orcid":false,"given":"Meredith","family":"Jackrel","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs","volume":"10","author":"Forman MS","year":"2004","unstructured":"Forman, M. S., Trojanowski, J. Q. & Lee, V. M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10, 1055\u20131063 (2004).","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41531-021-00203-9","article-title":"Alpha-synuclein research: defining strategic moves in the battle against Parkinson\u2019s disease","volume":"7","author":"Oliveira LMA","year":"2021","unstructured":"Oliveira, L. M. A. et al. Alpha-synuclein research: defining strategic moves in the battle against Parkinson\u2019s disease. npj Parkinson's Disease 7, 65 (2021).","journal-title":"npj Parkinson's Disease"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson CM","year":"2003","unstructured":"Dobson, C. M. Protein folding and misfolding. Nature 426, 884\u2013890 (2003).","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice","volume":"338","author":"Luk KC","year":"2012","unstructured":"Luk, K. C. et al. Pathological \u03b1-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"year":"2009","author":"Luk KC","key":"ref5","unstructured":"Luk, K. C. et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. U.S.A. 106, 20051\u201320056 (2009)."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The Amyloid State of Proteins in Human Diseases","volume":"148","author":"Eisenberg D","year":"2012","unstructured":"Eisenberg, D. & Jucker, M. The Amyloid State of Proteins in Human Diseases. Cell 148, 1188\u20131203 (2012).","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor JP","year":"2016","unstructured":"Taylor, J. P., Brown, R. H., Jr. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197\u2013206 (2016).","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/biom11071014","article-title":"Prion-Like Proteins in Phase Separation and Their Link to Disease","volume":"11","author":"Sprunger ML","year":"2021","unstructured":"Sprunger, M. L. & Jackrel, M. E. Prion-Like Proteins in Phase Separation and Their Link to Disease. Biomolecules 11, 1014 (2021).","journal-title":"Biomolecules"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMcibr065573","article-title":"Stress, aging, and neurodegenerative disease","volume":"355","author":"Morimoto RI","year":"2006","unstructured":"Morimoto, R. I. Stress, aging, and neurodegenerative disease. N Engl J Med 355, 2254\u20132255 (2006).","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1083\/jcb.201709072","article-title":"Pathways of cellular proteostasis in aging and disease","volume":"217","author":"Klaips CL","year":"2017","unstructured":"Klaips, C. L., Jayaraj, G. G. & Hartl, F. U. Pathways of cellular proteostasis in aging and disease. J. Cell Biol. 217, 51\u201363 (2017).","journal-title":"J. Cell Biol."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4161\/cc.28709","article-title":"Reversing deleterious protein aggregation with re-engineered protein disaggregases","volume":"13","author":"Jackrel ME","year":"2014","unstructured":"Jackrel, M. E. & Shorter, J. Reversing deleterious protein aggregation with re-engineered protein disaggregases. Cell cycle 13, 1379\u20131383 (2014).","journal-title":"Cell cycle"},{"key":"ref12","first-page":"11","article-title":"Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease","author":"Jackrel ME","year":"2017","unstructured":"Jackrel, M. E. & Shorter, J. Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease. Front. Neurosci. 11 (2017).","journal-title":"Front. Neurosci."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1172\/JCI35781","article-title":"Hsp104 antagonizes \u03b1-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease","volume":"118","author":"Lo Bianco C","year":"2008","unstructured":"Lo Bianco, C. et al. Hsp104 antagonizes \u03b1-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease. J Clin Invest 118, 3087\u20133097 (2008).","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cell.2012.09.038","article-title":"Operational Plasticity Enables Hsp104 to Disaggregate Diverse Amyloid and Nonamyloid Clients","volume":"151","author":"DeSantis ME","year":"2012","unstructured":"DeSantis, M. E. et al. Operational Plasticity Enables Hsp104 to Disaggregate Diverse Amyloid and Nonamyloid Clients. Cell 151, 778\u2013793 (2012).","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1093\/hmg\/ddi372","article-title":"Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease","volume":"14","author":"Vacher C","year":"2005","unstructured":"Vacher, C., Garcia-Oroz, L. & Rubinsztein, D. C. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. Hum Mol Genet 14, 3425\u20133433 (2005).","journal-title":"Hum Mol Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","article-title":"Human Hsp70 Disaggregase Reverses Parkinson's-Linked alpha-Synuclein Amyloid Fibrils","volume":"59","author":"Gao X","year":"2015","unstructured":"Gao, X. et al. Human Hsp70 Disaggregase Reverses Parkinson's-Linked alpha-Synuclein Amyloid Fibrils. Mol Cell 59, 781\u2013793 (2015).","journal-title":"Mol Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature14884","article-title":"Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation","volume":"524","author":"Nillegoda NB","year":"2015","unstructured":"Nillegoda, N. B. et al. Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation. Nature 524, 247\u2013251 (2015).","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e26319","DOI":"10.1371\/journal.pone.0026319","article-title":"The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system","volume":"6","author":"Shorter J","year":"2011","unstructured":"Shorter, J. The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PloS one 6, e26319 (2011).","journal-title":"PloS one"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay8826","article-title":"Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau","volume":"370","author":"Darwich NF","year":"2020","unstructured":"Darwich, N. F. et al. Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science 370 (2020).","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41586-021-03824-5","article-title":"DAXX represents a new type of protein-folding enabler","volume":"597","author":"Huang L","year":"2021","unstructured":"Huang, L. et al. DAXX represents a new type of protein-folding enabler. Nature 597, 132\u2013137 (2021).","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2018.03.002","article-title":"Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains","volume":"173","author":"Guo L","year":"2018","unstructured":"Guo, L. et al. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. Cell 173, 677\u2013692.e620 (2018).","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"108418","DOI":"10.1016\/j.celrep.2020.108418","article-title":"TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson's Disease","volume":"33","author":"Zhu G","year":"2020","unstructured":"Zhu, G. et al. TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson's Disease. Cell Rep 33, 108418 (2020).","journal-title":"Cell Rep"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.cdd.4402291","article-title":"The mitochondrial serine protease HtrA2\/Omi: an overview","volume":"15","author":"Vande Walle L","year":"2008","unstructured":"Vande Walle, L., Lamkanfi, M. & Vandenabeele, P. The mitochondrial serine protease HtrA2\/Omi: an overview. Cell Death & Differentiation 15, 453\u2013460 (2008).","journal-title":"Cell Death & Differentiation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrm3065","article-title":"HTRA proteases: regulated proteolysis in protein quality control","volume":"12","author":"Clausen T","year":"2011","unstructured":"Clausen, T., Kaiser, M., Huber, R. & Ehrmann, M. HTRA proteases: regulated proteolysis in protein quality control. Nat. Rev. Mol. Cell Biol. 12, 152\u2013162 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nchembio.1931","article-title":"Determinants of amyloid fibril degradation by the PDZ protease HTRA1","volume":"11","author":"Poepsel S","year":"2015","unstructured":"Poepsel, S. et al. Determinants of amyloid fibril degradation by the PDZ protease HTRA1. Nat Chem Biol 11, 862\u2013869 (2015).","journal-title":"Nat Chem Biol"},{"year":"2008","author":"Krojer T","key":"ref26","unstructured":"Krojer, T. et al. Interplay of PDZ and protease domain of DegP ensures efficient elimination of misfolded proteins. Proc. Natl. Acad. Sci. U.S.A. 105, 7702\u20137707 (2008)."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1110\/ps.073049407","article-title":"Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3","volume":"16","author":"Runyon ST","year":"2007","unstructured":"Runyon, S. T. et al. Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3. Protein Sci. 16, 2454\u20132471 (2007).","journal-title":"Protein Sci."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson's disease","volume":"14","author":"Strauss KM","year":"2005","unstructured":"Strauss, K. M. et al. Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099\u20132111 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1128\/MCB.00035-09","article-title":"Serine protease HtrA1 associates with microtubules and inhibits cell migration","volume":"29","author":"Chien J","year":"2009","unstructured":"Chien, J. et al. Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol. Cell. Biol. 29, 4177\u20134187 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed R","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486\u2013489 (2003).","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy","volume":"46","author":"Malpartida AB","year":"2021","unstructured":"Malpartida, A. B., Williamson, M., Narendra, D. P., Wade-Martins, R. & Ryan, B. J. Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy. Trends Biochem. Sci. 46, 329\u2013343 (2021).","journal-title":"Trends Biochem. Sci."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","article-title":"TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity","volume":"284","author":"Johnson BS","year":"2009","unstructured":"Johnson, B. S. et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329\u201320339 (2009).","journal-title":"J. Biol. Chem."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1000614","DOI":"10.1371\/journal.pbio.1000614","article-title":"Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS\/TLS","volume":"9","author":"Sun Z","year":"2011","unstructured":"Sun, Z. et al. Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS\/TLS. PLoS Biol. 9, e1000614 (2011).","journal-title":"PLoS Biol."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates","volume":"9","author":"Volpicelli-Daley LA","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9, 2135\u20132146 (2014).","journal-title":"Nat Protoc"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht W","year":"2013","unstructured":"Robberecht, W. & Philips, T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248\u2013264 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway KA","year":"1998","unstructured":"Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318\u20131320 (1998).","journal-title":"Nat. Med."},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024026","article-title":"Cellular Models for the Study of Prions","volume":"7","author":"Holmes BB","year":"2017","unstructured":"Holmes, B. B. & Diamond, M. I. Cellular Models for the Study of Prions. Cold Spring Harbor Perspectives in Medicine 7 (2017).","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"year":"2014","author":"Holmes BB","key":"ref38","unstructured":"Holmes, B. B. et al. Proteopathic tau seeding predicts tauopathy in vivo. Proc. Natl. Acad. Sci. USA 111, E4376-E4385 (2014)."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"Y. A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly","volume":"276","author":"Giasson BI","year":"2001","unstructured":"Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q. & Lee, V. M. Y. A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly. J. Biol. Chem. 276, 2380\u20132386 (2001).","journal-title":"J. Biol. Chem."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.str.2012.03.021","article-title":"Structural and Functional Analysis of HtrA1 and Its Subdomains","volume":"20","author":"Eigenbrot C","year":"2012","unstructured":"Eigenbrot, C. et al. Structural and Functional Analysis of HtrA1 and Its Subdomains. Structure 20, 1040\u20131050 (2012).","journal-title":"Structure"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara H","year":"2002","unstructured":"Fujiwara, H. et al. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cell.2013.11.047","article-title":"Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events","volume":"156","author":"Jackrel ME","year":"2014","unstructured":"Jackrel, M. E. et al. Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events. Cell 156, 170\u2013182 (2014).","journal-title":"Cell"},{"key":"ref43","first-page":"1175","article-title":"Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins","volume":"7","author":"Jackrel ME","year":"2014","unstructured":"Jackrel, M. E. & Shorter, J. Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. Dis. Model Mech. 7, 1175\u20131184 (2014).","journal-title":"Dis. Model Mech."},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1021\/acschembio.5b00765","article-title":"Disparate Mutations Confer Therapeutic Gain of Hsp104 Function","author":"Jackrel ME","year":"2015","unstructured":"Jackrel, M. E., Yee, K., Tariq, A., Chen, A. I. & Shorter, J. Disparate Mutations Confer Therapeutic Gain of Hsp104 Function. ACS Chem Biol (2015).","journal-title":"ACS Chem Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"11286","DOI":"10.1074\/jbc.RA119.009494","article-title":"Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma","volume":"294","author":"Ryan JJ","year":"2019","unstructured":"Ryan, J. J., Sprunger, M. L., Holthaus, K., Shorter, J. & Jackrel, M. E. Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma. J Biol Chem 294, 11286\u201311296 (2019).","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.celrep.2019.07.069","article-title":"Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and alpha-Synuclein Proteotoxicity","volume":"28","author":"Tariq A","unstructured":"Tariq, A. et al. Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and alpha-Synuclein Proteotoxicity. Cell Rep. 28, 2080\u20132095 e2086 (2019).","journal-title":"Cell Rep."},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1083\/jcb.201608022","article-title":"FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination","volume":"216","author":"Yasuda K","year":"2017","unstructured":"Yasuda, K., Clatterbuck-Soper, S. F., Jackrel, M. E., Shorter, J. & Mili, S. FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination. J Cell Biol 216, 1015\u20131034 (2017).","journal-title":"J Cell Biol"},{"key":"ref48","first-page":"25","article-title":"Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology","author":"Sprunger ML","year":"2022","unstructured":"Sprunger, M. L., Lee, K., Sohn, B. S. & Jackrel, M. E. Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology. iScience 25 (2022).","journal-title":"iScience"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/19336896.2015.1020277","article-title":"Engineering enhanced protein disaggregases for neurodegenerative disease","volume":"9","author":"Jackrel ME","year":"2015","unstructured":"Jackrel, M. E. & Shorter, J. Engineering enhanced protein disaggregases for neurodegenerative disease. Prion 9, 90\u2013109 (2015).","journal-title":"Prion"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1021\/jacs.6b03463","article-title":"HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective","volume":"138","author":"Chu Q","year":"2016","unstructured":"Chu, Q. et al. HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective. J. Am. Chem. Soc. 138, 9473\u20139478 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/bi020429y","article-title":"Jr. The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation","volume":"42","author":"Kessler JC","year":"2003","unstructured":"Kessler, J. C., Rochet, J. C. & Lansbury, P. T., Jr. The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry 42, 672\u2013678 (2003).","journal-title":"Biochemistry"},{"key":"ref52","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797452","article-title":"A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing","volume":"37","author":"Wang A","year":"2018","unstructured":"Wang, A. et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. Embo J 37 (2018).","journal-title":"Embo J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","article-title":"Parkinson\u2019s disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics","volume":"294","author":"Yamasaki TR","year":"2019","unstructured":"Yamasaki, T. R. et al. Parkinson\u2019s disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics. J. Biol. Chem. 294, 1045\u20131058 (2019).","journal-title":"J. Biol. Chem."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2570571\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2570571\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T07:07:19Z","timestamp":1710832039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2570571\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":53,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2570571\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-024-46538-8","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,8,22]]},"subtype":"preprint"}}